‘Cancer Risk’ of Miscarriage Drug… a 2006 Study

Daughters of mothers who took the drug DES during their pregnancies may have a higher risk of breast cancer as they get older, but this does not mean that they will definitely develop the disease.

 

Women whose mothers used an anti-miscarriage drug in pregnancy have double the risk of breast cancer than others their age, a US study suggests.

Read Cancer risk of miscarriage drug
BBC News August 2006.

More DES DiEthylStilbestrol Resources

• DES studies on cancers and screening.
• DES studies on epigenetics and transgenerational effects.
• DES studies on fertility and pregnancy.
• DES studies on gender identity and psychological health.
• DES studies on in-utero exposure to DES and side-effects.
• DES studies on the genital tract.
• Papers on DES lawsuits.
• DES videos and posts tagged DES, the DES-exposed, DES victims.